1. Featured Cover. Issue 10 (9th September 2022) Authors: Phillips, Jonathan A.; Taub, Mitchell E.; Bogdanffy, Matthew S.; Yuan, Jing; Knight, Brian; Smith, James D.; Ku, Warren W. Journal: Journal of applied toxicology Issue: Volume 42:Issue 10(2022) Page Start: i Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mode of action and human relevance assessment of male CD‐1 mouse renal adenocarcinoma associated with lifetime exposure to empagliflozin. Issue 10 (18th April 2022) Authors: Phillips, Jonathan A.; Taub, Mitchell E.; Bogdanffy, Matthew S.; Yuan, Jing; Knight, Brian; Smith, James D.; Ku, Warren W. Journal: Journal of applied toxicology Issue: Volume 42:Issue 10(2022) Page Start: 1570 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Nonclinical Safety of the Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin. (November 2014) Authors: Bogdanffy, Matthew S.; Stachlewitz, Robert F.; van Tongeren, Susan; Knight, Brian; Sharp, Dale E.; Ku, Warren; Hart, Susan Emeigh; Blanchard, Kerry Journal: International journal of toxicology Issue: Volume 33:Number 6(2014) Page Start: 436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tg.rasH2 Mouse Model for Assessing Carcinogenic Potential of Pharmaceuticals: Industry Survey of Current Practices. (May 2020) Authors: Bogdanffy, Matthew S.; Lesniak, Jacob; Mangipudy, Raja; Sistare, Frank D.; Colman, Karyn; Garcia-Tapia, David; Monticello, Thomas; Blanset, Diann Journal: International journal of toxicology Issue: Volume 39:Number 3(2020) Page Start: 198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗